Free Biopharma Daily Stock Updates - 02/23/21

$XBI $150.83 -2% 📉

Want to access our searchable database of catalysts and more? Get access to BiopharmIQ for 30 days free, no credit card required. Check it out here!

Covid Updates

$RDHL -13% expands ph 2/3 covid-19 study of oral opaganib for severe covid-19 patients to the US. source


Pipeline Updates

$PLX -3% Positive topline results from ph 3 open-label study for Fabry disease. source


$SCPH +1% received meeting minutes from Type A meeting with FDA following CRL. FDA noted the outstanding questions relate to pre-approval inspections and bench testing. No additional clinical data required. Company plans to resubmit NDA in Q3 2021. source




0 comments

*Disclaimer: Information provided on bpiq.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.

SITE